NDA Director Greg Ibach promotes Nebraska’s ag-products in Asia

Mar 26, 2015

Visiting Malaysia and Philippines

Along with United States Department of Agriculture Secretary Michael Scuse, Mark McHargue, first vice president of the Nebraska Farm Bureau and Stan Garbacz, Nebraska Department of Agriculture’s (NDA) international trade representative, NDA Director Greg Ibach is travelling within Southeast Asia to promote agricultural products from the Cornhusker State.

“I am pleased Under Secretary Scuse invited Nebraska to participate in this important trade mission. There is a tremendous opportunity for our agricultural exports to continue to grow in Southeast Asia, and I hope to be able to forge relationships and open the door to future trade deals for Nebraska while I am here,” said Ibach in a press release.

The delegation also features representatives Idaho, Iowa, North Dakota, Texas and Virginia as well as 21 agribusinesses and organizations. They’ll spend their time in Kuala Lumpur, Malaysia as well as Manila, Philippines and will meet with potential business partners from Burma and Thailand.

Ibach estimates exports into Southeast Asia have doubled over five years from $2.7 billion in 2009, reaching about $5.4 billion in 2014.

Nebraska beef exported to the Philippines has seen the most increase. In 2009, beef exports were valued around $905,000 and in the past five years has skyrocketed to $7.9 million worth. Beef to Thailand has also experienced growth with exports rising from $33,000 to $973,000 within the same five year time period.

Join the conversation and tell us the kinds of opportunities you would like to see with these new relationships being formed.

Will you change your farm operation and incorporate more beef?

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.